The safety and efficacy of the biosimilar anti-CD20 antibody, Truxima, in haematological malignancy

被引：0
|
作者：
Lo, I. [1 ]
Bansal, S. [1 ]
Arami, S. [1 ]
机构：
[1] London Northwest Healthcare NHS Trust, London, England
来源：
LEUKEMIA RESEARCH | 2018年 / 73卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP-48
引用
收藏
页码：S51 / S51
页数：1
相关论文
共 50 条
  • [11] Antigenic modulation limits the efficacy of anti-CD20 antibodies: implications for antibody selection
    Beers, Stephen A.
    French, Ruth R.
    Chan, H. T. Claude
    Lim, Sean H.
    Jarrett, Timothy C.
    Vidal, Regina Mora
    Wijayaweera, Sahan S.
    Dixon, Sandra V.
    Kim, Hyungjin
    Cox, Kerry L.
    Kerr, Jonathan P.
    Johnston, David A.
    Johnson, Peter W. M.
    Verbeek, J. Sjef
    Glennie, Martin J.
    Cragg, Mark S.
    BLOOD, 2010, 115 (25) : 5191 - 5201
  • [12] Anti-CD20 monoclonal antibody/thalidomideMyeloproliferative disorder in an elderly patient (first report with anti-CD20 monoclonal antibody): case report
    Reactions Weekly, 2001, 855 (1) : 7 - 7
  • [13] CLINICAL EVALUATION OF BIOSIMILAR ANTI-CD20 MONOCLONAL ANTIBODY WITH RITUXIMAB IN THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS
    Iacovou, Anna
    Heath, Rebecca
    Ashley, Caroline
    Antonelou, Marilina
    Salama, Alan
    RHEUMATOLOGY, 2019, 58
  • [14] CLINICAL EVALUATION OF BIOSIMILAR ANTI-CD20 MONOCLONAL ANTIBODY WITH RITUXIMAB IN THE TREATMENT OF ANCA-ASSOCIATED VASCULITIS
    Heath, Rebecca
    Iacovou, Anna
    Ashley, Caroline
    Antonelou, Marilina
    Salama, Alan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [15] Anti-CD20 monoclonal antibody/bendamustine/polatuzumab vedotinFebrile neutropenia and haematological toxicity: 2 case reports
    Reactions Weekly, 2020, 1817 (1) : 30 - 30
  • [16] BLOCKING B-CELLS (ANTI-CD20/ANTI-CD20)
    Isenberg, David A.
    RHEUMATOLOGY, 2015, 54 : 1 - 1
  • [17] Efficacy and Safety of Monoclonal Anti-CD20 Antibody Rituximab Combined Cyclophosphamide in Treatment of Refractory and Recurrent Autoimmune Hemolytic Anemia
    Shao, Zonghong
    Liu, Hong
    Xing, Limin
    Wu, Yuhong
    Qu, Wen
    Liang, Yong
    Guan, Jing
    Wang, Guojin
    Wang, Xiaoming
    Song, Jia
    Li, Lijuan
    Wang, Huaquan
    BLOOD, 2012, 120 (21)
  • [18] Rituximab (anti-CD20 monoclonal antibody) in children with chronic refractory symptomatic immune thrombocytopenic purpura: Efficacy and safety of treatment
    Parodi, Emilia
    Nobili, Bruno
    Perrotta, Silverio
    Matarese, Sofia Maria Rosaria
    Russo, Giovanna
    Licciardello, Maria
    Zecca, Marco
    Locatelli, Franco
    Cesaro, Simone
    Bisogno, Gianni
    Giordano, Paola
    De Mattia, Domenico
    Ramenghi, Ugo
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2006, 84 (01) : 48 - 53
  • [19] The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis
    Wu, Xin
    Tan, Xin
    Zhang, Jie
    Wang, Zilan
    Wu, Wenxue
    Wang, Shixin
    Liu, Yanfei
    Wang, Zhong
    CNS DRUGS, 2022, 36 (11) : 1155 - 1170
  • [20] The Efficacy and Safety of Anti-CD20 Antibody Treatments in Relapsing Multiple Sclerosis: A Systematic Review and Network Meta-analysis
    Xin Wu
    Xin Tan
    Jie Zhang
    Zilan Wang
    Wenxue Wu
    Shixin Wang
    Yanfei Liu
    Zhong Wang
    CNS Drugs, 2022, 36 : 1155 - 1170
12345